Zynerba Pharmaceuticals, Inc. Quarterly Other Assets, Current in USD from Q4 2014 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Zynerba Pharmaceuticals, Inc. quarterly Other Assets, Current history and growth rate from Q4 2014 to Q2 2023.
  • Zynerba Pharmaceuticals, Inc. Other Assets, Current for the quarter ending June 30, 2023 was $629K, a 6.42% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $629K -$43.1K -6.42% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $566K +$325K +135% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $538K +$341K +173% Dec 31, 2022 10-Q 2023-08-14
Q3 2022 $511K -$126K -19.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $672K +$100K +17.5% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $241K -$66.7K -21.7% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $197K -$74K -27.3% Dec 31, 2021 10-K 2023-03-28
Q3 2021 $637K +$370K +138% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $572K +$288K +101% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $308K -$44.9K -12.7% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $271K -$115K -29.7% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $268K -$133K -33.2% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $284K -$138K -32.7% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $353K -$41.8K -10.6% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $386K -$40.4K -9.49% Dec 31, 2019 10-K 2021-03-10
Q3 2019 $401K +$95.9K +31.5% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $422K +$188K +80.4% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $394K +$105K +36.3% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $426K +$196K +84.9% Dec 31, 2018 10-K 2020-03-10
Q3 2018 $305K +$91.3K +42.8% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $234K +$25.7K +12.4% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $289K +$155K +115% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $230K +$194K +538% Dec 31, 2017 10-K 2019-03-11
Q3 2017 $213K +$45K +26.7% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 $208K +$183K +717% Jun 30, 2017 10-Q 2017-08-01
Q1 2017 $135K +$70.2K +109% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $36.1K -$15.7K -30.3% Dec 31, 2016 10-K 2018-03-12
Q3 2016 $168K +$119K +244% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 $25.5K Jun 30, 2016 10-Q 2016-08-11
Q1 2016 $64.5K Mar 31, 2016 10-Q 2016-05-12
Q4 2015 $51.8K +$29.7K +134% Dec 31, 2015 10-K 2017-03-27
Q3 2015 $49K Sep 30, 2015 10-Q 2015-11-12
Q4 2014 $22.2K Dec 31, 2014 10-K 2016-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.